Pharma News

European Medicines Agency (EMA) confirms acceptance of the Marketing Authorization Application (MAA) for DMB-3115, a biosimilar of Stelara® (Ustekinumab). The MAA has been submitted by Accord Healthcare, Intas’ wholly owned subsidiary on June 23rd, and the EMA accepted the MAA submission on 14th July.

After many years of penance, when the degree comes in hand, then the dreams get wings, and the mind is eager to fly in the blue sky. A similar scene was seen on Saturday at the Convocation - 2023 of IIHMR University, Jaipur. Dr. P.R. Sodani, President, IIHMR University, said this year, 308 students were awarded degrees in the convocation programme; out of 308 students, 201 students of MBA Hospital and Health Management, 77 students of MBA Pharmaceutical Management, 21 students of MBA Development Management and 9 students of PhD were awarded degrees.

Women have used birth-control pills since the 1960s, but researchers still do not know everything about the body's complex reaction to the small, hormone-laden pill.

Researchers from Aarhus University and the United States have studied the stress response of 131 young women when having a blood sample taken. Some of the women were on birth-control pills, while others were not. The researchers specifically measured the levels of the stress hormone ACTH in the women’s blood.

Scientists have designed an AI tool that can rapidly decode a brain tumor’s DNA to determine its molecular identity during surgery - critical information that under the current approach can take a few days and up to a few weeks.

Knowing a tumor’s molecular type enables neurosurgeons to make decisions such as how much brain tissue to remove and whether to place tumor-killing drugs directly into the brain - while the patient is still on the operating table.

The Inaugural Regulatory Program of Eminence Business Media, Pharma Regulatory Conclave 2023 set a very high benchmark for conferences based off learning and rejuvenation. The program was designed with a unique framework with one day virtual day program on 30th June and a two-day in-person conference at Hilton Resort, North Goa on July 5th - 6th.

The Pharma Computer Software Assurance 2023 conference third edition set remarkably high session originality and creativity standards, providing attendees with an engaging program full of valuable learning opportunities. This two-day in-person event occurred at Novotel Mumbai, Juhu Beach, on June 22nd and 23rd, 2023. The conference unique program design achieved a balance between CSV and CSA.

Novavax, Inc a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, has been granted full Marketing Authorization (MA) by the European Commission in the European Union (EU) for Nuvaxovid  (NVX-CoV2373). This decision follows positive opinion for a full MA from the Committee for Medicinal Products for Human Use of the European Medicines Agency. The vaccine is now fully authorized for use as a primary series in individuals aged 12 and older and as a booster dose in adults aged 18 and older for the prevention of COVID-19.

For the first time, scientists have shown that gut bacteria differences are associated with later development of juvenile idiopathic arthritis, a debilitating rheumatic childhood disease, and that these differences are present years before the disease is diagnosed.

The Pharmacy Council of India (PCI) has urged the Jharkhand government to recall its decision of granting permission for opening pharmacies in rural areas without registered pharmacists.